# Safety and Efficacy of EcoActive on Intestinal Adherent Invasive E. Coli in Patients With Inactive Crohn's Disease

> **NCT03808103** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Intralytix, Inc.** · enrollment: 30 (estimated)

## Conditions studied

- Crohn Disease

## Interventions

- **BIOLOGICAL:** Placebo
- **BIOLOGICAL:** Bacteriophage preparation

## Key facts

- **NCT ID:** NCT03808103
- **Lead sponsor:** Intralytix, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-05-01
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-06-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-06-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03808103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03808103, "Safety and Efficacy of EcoActive on Intestinal Adherent Invasive E. Coli in Patients With Inactive Crohn's Disease". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03808103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*